Author Description

This edition has totally revised chapters on drug regulation in the USA, with new contributor, Dr Peter Barton Hutt formerly FDA Special Counsel. New contributions regarding pharmaco–economics are covered in two new chapters. There are 22 chapters in all with contributions from pharmaceutical physicians, drug regulators, health economists and lawyers from UK, USA and Japan.